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ABSTRACT: The protective capacity and applications of biomimetically mineralized biomacromolecule zeolitic imidazolate 
framework (ZIF) composites are likely dependent on the localization of the biomolecule and the topology of the mineralized 
ZIF coating. Herein we identify reaction conditions to reliably yield the porous ZIF-8 sodalite topology (high ZIF-8 precursor 
concentrations; high 2-methylimidazole:Zn2+ ratios) in preference to other more dense phases. Furthermore, protocols to 
universally prepare biocomposites with a range of biomacromolecules are canvassed. Through the use of fluorophore-
tagged proteins and confocal laser scanning microscopy (CLSM) we further establish the positioning of biomolecules within 
ZIF-8 crystals. CLSM reveals subsurface localization with fluorescein-tagged bovine serum albumin (BSA) or full encapsu-
lation with rhodamine B-tagged BSA. These observations allowed us to demonstrate that core-shell ZIF-8 growth strategies 
afford complete encapsulation, with varying thicknesses of potentially active biocomposite or protective ZIF-8. The demon-
strated control over ZIF topology (enabling mass transport) and biomacromolecule localization is critical for applications 
of MOF biocomposites in catalysis. 
INTRODUCTION 
Metal-organic frameworks (MOFs) are a class of ma-
terials well-known for their high degree of crystallinity and 
ultra-high porosity.1-3 A salient feature of MOF chemistry 
is that their modular synthesis from organic links and 
metal nodes allows for precise control of structure, pore 
size and chemical functionality.4 Recently, MOFs have 
been explored for their potential to form novel biocompo-
sites with proteins,5-7 viruses8 and living cells,9, 10,11 by a 
process termed biomimetic mineralization.12 To date, the 
most widely studied MOF for this application is zeolitic im-
idazolate framework-813, 14 (ZIF-8 or sod-Zn(mIM)2, sod = 
sodalite, mIM = 2-methylimidazole).12, 15-17 Sod-Zn(mIM)2 
is a robust, three dimensional network, composed of tet-
rahedral Zn2+ nodes linked together via mIM ligands,18, 19 
which can be synthesized in aqueous conditions at room 
temperature.20 Typically, Zn2+ and mIM are combined with 
the target biomacromolecules (or cells) in aqueous solu-
tion at room temperature and the MOF-based biocompo-
site is formed within minutes.5, 6 Characterization of the 
MOF biocomposites formed from proteins or enzymes in-
dicates that the biomacromolecules are encapsulated 
within the ZIF-8 crystals.12 The sod-Zn(mIM)2 coating was 
shown to protect the biomacromolecules from conditions 
that would normally lead to their denaturation.5, 6, 12 For 
example, when encapsulated within sod-Zn(mIM)2 crys-
tallites, the enzyme horseradish peroxidase (HRP) re-
tained activity after immersion in boiling water or N,N’-di-
methylformamide (DMF, b.p. 153 °C).6 Accordingly, these 
novel MOF biocomposites show great promise for appli-
cation to industrial biocatalysis where strategies for en-
hancing enzyme stability are of significant interest.12, 21, 22  
An important aspect of this chemistry that has not been 
addressed is the effect of reaction conditions on the topol-
ogy of the ZIF coating.23-25 ZIF-8 has a sodalite topology 
with pore apertures and diameters of ca. 3.4 Å and 11.4 
Å, respectively, and a BET surface area of ca. 1500 m2 g-
1.13, 14 However, a number of experimental and theoretical 
studies have shown that the sod structure is one of many 
energetically accessible polymorphs for networks con-
structed from Zn2+ and mIM building units.24-27 Indeed, in 
neat H2O, a variety of different structures can be synthe-
sized by simply modifying the precursor concentration 
and/or molar ratio between Zn2+ and mIM.23, 28, 29 Similarly, 
we have found that minor changes to the standard exper-
imental conditions,6 such as the ratio of the ZIF precur-
sors, also leads to a variety of different network topolo-
gies. Thus, to reliably afford specific ZIF structures, a fun-
damental understanding of the reaction conditions is re-
quired. This data is critical to the development of these 
MOF biocomposites for catalytic applications, as the 
framework topology can have a marked effect on the per-
formance characteristics of the catalyst.30 For example, 
sod-Zn(mIM)2 is porous to N2 while the more thermody-
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namically stable polymorph, dia-Zn(mIM)2 (dia = dia-
mond) does not adsorb N2 due to its more densely packed 
structure.23 As a result, these two ZIF coatings would con-
fer distinct size selective and mass diffusion properties to 
biocomposites.31 Also, the spatial distribution of the biom-
acromolecules within the crystals will influence the cata-
lytic efficacy of the MOF biocomposites.28 Comparable 
studies have shown that the distribution of inorganic na-
noparticles within ZIF-8 crystals is dependent on synthetic 
conditions.32 Thus, it can be anticipated that, similarly, the 
distribution of biomacromolecules throughout the sod-
Zn(mIM)2 crystallite can be controlled by modifying the 
synthesis conditions. Herein, we carried out a systematic 
study to ascertain the specific synthesis conditions re-
quired to achieve pure sod-Zn(mIM)2 biocomposites and 
present a facile and general method for the precise con-
trol of the particle size of the biocomposites. Furthermore, 
we studied the spatial distribution of the biomacromole-
cules within the ZIF crystals by encapsulating fluoro-
phore-tagged bovine serum albumin (fluorescein-tagged 
BSA (FBSA) and rhodamine B-tagged BSA (RbBSA)) and 
examining them via confocal laser scanning microscopy 
(CLSM). The exploration of MOF-based biocomposites 
where biomacromolecules are encapsulated within the 
crystals is a burgeoning field5, 6, 9, 11, 15-17, 32 and this study 
provides a blueprint for how to tailor the physical proper-
ties of the composites and provides insight into the under-
lying growth mechanism of these systems. 
EXPERIMENTAL SECTION 
Syntheses 
All chemicals, biomolecules (alcohol oxidase, solution 
from Pichia pastoris, buffered aqueous solution, 10-40 
units mg-1 protein (biuret), Sigma-Aldrich; bovine serum 
albumin, ≥96%, lyophilized powder (agarose gel electro-
phoresis), Sigma-Aldrich; peroxidase from horseradish, 
lyophilized powder, beige, ~150 U mg-1, Sigma-Aldrich; 
urease, from Canavalia ensiformis (Jack bean), Type III, 
powder, 15,000-50000 U g-1, Sigma-Aldrich; hemeoglobin 
human, lyophilized powder, Sigma-Aldrich; myoglobin, 
from equine skeletal muscle, 95-100%, essential salt-free, 
lyophilized powder, Sigma-Aldrich; catalase, from bovine 
liver, lyophilized powder, 2,000-5,000 U mg-1 protein, 
Sigma-Aldrich; lysozyme, egg white, >20,000 U mg-1, As-
tra Scientific; trypsin, BRP, European Pharmacopoeia 
(EP) reference standard, Sigma-Aldrich) and solvents 
were purchased from commercial sources and used as 
received without further purification. 
Fluorophore-tagged biomolecules 
Fluorescein isothiocyanate (FITC, 0.5 mg) or rhoda-
mine B isothiocyanate (RbITC, 0.5 mg), and biomacro-
molecule (40 mg, bovine serum albumin (BSA), horserad-
ish peroxidase (HRP), trypsin (TR), hemoglobin (HGB), 
alcohol oxidase (AOx), urease, and or myoglobin (MB)) 
were dissolved in carbonate-bicarbonate aqueous buffer 
solution (4 mL, 0.1 M, pH 9.2) and left for twelve hours in 
darkness at 4°C under gentle stirring. The fluorophore-
tagged biomacromolecule (fluorescein-tagged biomacro-
molecules; F-BSA, F-AOx, F-HRP, F-HGB, F-MB and F-
TR, F-urease and rhodamine B-tagged biomacromole-
cules; Rb-BSA, Rb-AOx, Rb-HRP, Rb-HGB, Rb-MB and 
Rb-TR, Rb-urease) was recovered by passing the reac-
tion mixture through an Illustra NAP-25 column (GE 
Healthcare Life Sciences, NSW, Australia). The crude 
protein/enzyme solution was concentrated through a 10 
kDa membrane by centrifugation at 4 °C (4,000 rpm for 
20 min), followed by solvent-exchange with ultrapure wa-
ter. The concentration/solvent-exchange process was re-
peated two times to ensure the complete removal of buffer 
salts in the solution. Thereafter, the concentrated fluoro-
phore-tagged protein/enzyme solution was passed again 
through an NAP-25 column to ensure the completely re-
moval of unreacted FITC or RbITC molecules. The ob-
tained fluorophore-tagged protein/enzyme solution was 
stored in darkness at 4 °C. 
Synthesis parameter screening for the ZIF poly-
morphs 
In a typical experiment for ZIF polymorph synthesis, 
the desired volume of 0.24 M aq. Zn(OAc)2·2H2O and 
3.84 M aq. 2-methylimidazole (HmIM) were mixed in wa-
ter. Zn(OAc)2·2H2O concentration (80 mM, 40 mM, 20 
mM, and 10 mM) and HmIM/Zn molar ratio (HmIM/Zn2+ = 
16, 8, 4, 2, and 1) were adjusted to study their effect on 
ZIF polymorph formation. The reaction mixture was left 
under static or stirred conditions (magnietic stirrer bar) at 
room temperature for 24 h. After synthesis, the precipi-
tates were collected by centrifugation (10,000 rpm for 5 
min), air-dried, and measured by PXRD without washing. 
The PXRD patterns were compared to the simulated data 
to identify the ZIF phases in samples. Results were then 
summarized as ternary plots of [Zn(OAc)2] versus [HmIm] 
versus [H2O]. 
Synthesis parameter screening for biomimetic miner-
alized growth of sod-Zn(mIM)2 
The procedure for screening the synthesis parameters 
for the biomimetically mineralized growth of sod-
Zn(mIM)2 was analogous to abovementioned screening 
experiments for the ZIF polymorphs with the exception 
that 1 mg of biomacromolecule was added in the reaction 
mixture. Nine types of biomacromolecules were chosen 
for the screening experiments: BSA, FBSA, HRP, cata-
lase, TR, HGB, AOx, lysozyme, and MB. 
Synthesis method for FBSA-@-sod-Zn(mIM)2 
FBSA-@-sod-Zn(mIM)2 was synthesized in water with 
40 mM of Zn(OAc)2·2H2O, 640 mM of HmIM and 0.33 mg 
mL-1 FBSA at room temperature under static condition for 
24 h. The precipitate was recovered by centrifugation at 
10,000 rpm for 5 min and then washed, sonicated, and 
centrifuged twice each in pH 7.5 TBS buffer (1.5 mL, TBS 
= tris-buffered saline, 50 mM Tris-Cl and 150 mM NaCl) 
followed by ethanol (1.5 mL). Thereafter, the sample was 
immersed in 10% w/w sodium dodecyl sulfate (SDS) so-
lution for 30 min (1.5 mL, in pH 7.5 TBS buffer) to remove 
surface adsorbed FBSA. This was followed by pH 7.5 TBS 
buffer (1.5 mL, 2x) and ethanol (1.5 mL, 2x) washes to 
remove residual surfactant. 
Characterization 
Powder X-ray diffraction (PXRD) 
PXRD patterns were obtained using a D4 ENDEAVOR 
X-ray Diffractometer from Bruker. A Co anode was used 
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to produce Kα radiation (λ = 1.78897 Å). Flat plate diffrac-
tion data was collected from the range 2θ = 5-40 °. The 
PXRD data were modified by PowDLL Converter (version 
2.68.0.0) and expressed as the copper-source irradiated 
patterns (λ = 1.54056 Å). 
Thermogravimetric analysis (TGA) 
TGA data was collected on a Simultaneous Thermal 
Analysis–STA (TGA/DSC) from LINSEIS THERMAL 
ANALYSIS. Approximately 5 mg of sample was placed on 
a ceramic pan and heated from 30 to 800 °C at a rate of 
5 °C min-1. Each sample was heated under a constant flow 
of ca. 30 L min-1 air. 
Fourier transform infrared (FTIR) spectroscopy 
FTIR spectra of ZIFs and biomacromolecule/ZIF com-
posites were obtained on a Perkin Elmer Spectrum 100 
FT-IR Spectrometer using approximately 0.5 mg of 
ground sample. Sixteen scans were recorded over the 
range of 40000-650 cm-1. 
Gas sorption 
Gas adsorption isotherms were obtained on a Mi-
cromeritics 3Flex Surface Characterisation Analyser. Ap-
proximately 20 mg of sample was placed into a glass anal-
ysis tube and degassed under dynamic vacuum for 12 h 
at 105 °C prior to measurement. 
Nitrogen (N2) adsorption and desorption isotherms 
were measured at 77 K. The isotherms were then ana-
lyzed to determine the Brunauer-Emmet-Teller (BET) sur-
face area using the MicroActive software (Version 3.00, 
Micromeritics Instrument Corp. 2013). 
Confocal laser scanning microscopy (CLSM) 
The presence and spatial location of the fluorophore-
tagged biomolecules in (or on) the MOFs composites was 
determined using CLSM technique (Olympus FV3000 
Confocal Laser Scanning Microscope, OLYMPUS). The 
fluorescein-tagged biomolecules were excited at 488 nm 
and the fluorescence signal was collected in a window 
from 495 to 545 nm. The rhodamine B-tagged biomole-
cules were excited at 561 nm and the fluorescence signal 
was collected in a window from 570 to 620 nm. 
Fluorescence spectrophotometry 
Fluorescence measurements of solution samples 
were carried out using a Varian Cary Eclipse Fluores-
cence Spectrophotometer. 
Scanning Electron Microscopy (SEM) 
SEM images were collected using a Philips XL30 Field 
Emission Scanning Electron Microscope (FESEM). Prior 
to analysis, the samples were dispersed in ethanol by 
sonication, drop-cast on a 12 mm aluminum SEM stage, 
and sputter-coated with a 5 nm platinum thin film. 
Zeta potential measurements 
BSA, FBSA, or RbBSA (1 mg) was dissolved in HmIM 
aqueous solution of HmIm (3 mL, 640 mM), the pH of the 
mixture was adjusted to 9.5 using 1 M HCl. Zeta potentials 
for the protein samples were obtained on a Malvern 
ZetaSizer dynamic light scattering instrument using a 
folded capillary zeta potential cell. 
RESULTS AND DISCUSSION 
ZIFs are composed of tetrahedral metal centers con-
nected via imidazole links.33 This node structure gives rise 
to networks that resemble silica polymorphs.33, 34 A salient 
difference between these materials is that the structures 
of ZIFs are largely determined by the chemistry of the 
bridging imidazole units.26, 34 However, for mIM and Zn2+ 
a number of different polymorphs have been experimen-
tally observed such as dia and kat (katsenite).23-25, 29 
Based on the packing density and orientation of the or-
ganic ligands, these topologies can have vastly different 
physical properties.23-25 In our examination of the biomi-
metic mineralization of different proteins we found that a 
stoichiometric HmIM/Zn ratio of 4:1 afforded a variety of 
structural topologies in addition to sod (Figure S1-S2).28, 
29 Further, we found that the preparation conditions (i.e. 
stirring versus non-stirred solutions) affected the reaction 
rate of ZIF formation. Thus, we were motivated to under-
stand the influence of reaction conditions on these sys-
tems and to uncover a general method to synthesize bio-
composites of predetermined topology. To achieve this 
aim we carried out systematic screening experiments to 
ascertain the effect of the HmIM/Zn ratio on the structure 
of the biocomposite (Figure 1). We varied the zinc acetate 
concentration in the reaction mixture (80, 40, 20, and 10 
mM), HmIM/Zn molar ratio (HmIM/Zn = 16, 8, 4, 2, and 1), 
mechanical agitation (stirred and non-stirred solutions), 
and biomacromolecule (BSA, FBSA, HRP, catalase, TR, 
HGB, AOx, lysozyme, and MB) (Figure 1b, S1, and S2). 
The typical synthesis procedure was carried out as fol-
lows: an aqueous solution of HmIM was mixed with an 
aqueous solution of the biomacromolecule (or water for 
control experiments), followed by the addition of an aque-
ous solution of zinc acetate. It is worth noting that this ad-
dition sequence of reactants was chosen because: 1) the 
alkaline HmIM aqueous solution facilitated protein disso-
lution; 2) the formation of precipitates is prevented (in the 
absence of HmIM ligand, zinc acetate mixed with proteins 
can induce the formation of precipitates). After prepara-
tion, the mixture was left at room temperature for 24 h; 
subsequently the ZIF biocomposites (or pure ZIFs) were 
recovered by centrifugation and air-dried. The precipitates 
were examined by PXRD without further treatment and 
the resulting PXRD patterns were compared to the simu-
lated data to identify the ZIF phases present. A summary 
of the results is presented (Figures 1b, S1, and S2) as 
ternary plots. 
In the absence of biomacromolecules, the PXRD re-
sults show that a high precursor concentration 
(Zn(OAc)2·2H2O and HmIM) and/or a high HmIM/Zn molar 
ratio favor the formation of sod-Zn(mIM)2, (Figure S1 and 
S2). However, at dilute and/or low HmIM/Zn molar ratio 
dia-Zn(mIM)2, an amorphous product (amorph-Zn(mIM)2, 
amorph = amorphous) and new structures of unidentified 
topologies (named U12, U13, and U14) were found to be 
the dominant products (Figure 1b, S1, and S2). We noted 
that stirring during synthesis accelerated product for-
mation; however, the general trend of the phase diagrams 
(vide infra) remained unchanged (Figure 1b and S2). U14 
was produced exclusively when stirred, however, U12 can 
be formed with or without stirring (Figure 1b, S2, and S4). 
The three structures that could not be identified as known 
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ZIF materials (U12, U13, and U14) were further investi-
gated (Figure S1-S9). FTIR and TGA analysis performed 
on U13 are consistent with its assignment as a form of 
zinc hydroxide (Figure S6-S9). FTIR and TGA studies 
confirmed the presence of a HmIM ligand, with a HmIM/Zn 
molar ratio of 2 for U14 and 1 for U12 (Figure S6-S7). 
According to the ternary plot, we synthesized sod-
Zn(mIM)2, dia-Zn(mIM)2, U12, and U14 to further study 
the properties of these polymorphs. The phase purity of 
the bulk samples were confirmed by PXRD analysis (Fig-
ure S4 and S5) and the particle morphology was as-
sessed by SEM (Figure S8). Analysis of the SEM images 
showed that sod-Zn(mIM)2 afforded rhombic dodecahe-
dron crystals of size distribution 0.85 ± 0.1 µm (Figure S8). 
However, for dia-Zn(mIM)2, U12, and U14 structures, 
elongated hexagonal plates, octahedral, and spindle-
shape plate morphologies were observed, respectively 
(Figure S8). The permanent porosity of each material was 
assessed by 77K N2 gas adsorption isotherms. Analysis 
of these data yielded Brunauer-Emmett-Teller surface 
area values of 1358.5, 22.9, 50.9, and 26.0 m2 g-1 for sod-
Zn(mIM)2, dia-Zn(mIM)2, U12, and U14, respectively (Fig-
ure S9). In summary, these data imply that dia-Zn(mIM)2, 
U12, and U14 are densely packed polymorphs which is 
consistent with the synthetic conditions used. For exam-
ple, high HmIM concentrations are known to enhance the 
rate of reaction by increasing the pH of the reaction mix-
ture,35 thus leading to the isolation of the lower density 
sod framework. Furthermore, dilute reactant concentra-
tions are known to give rise to dense ZIFs24 which are 
consistent with the physical properties of dia-Zn(mIM)2, 
U12, and U14. The phase screening protocol for the bio-
mimetically mineralized growth of the ZIF-biocomposites 
were analogous to those performed in the absence of bi-
omacromolecules (vide supra) with the exception that an 
aqueous solution of 1 mg of protein/enzyme (in place of 
water) was added to the reaction mixture (Figure 1b, S1, 
and S2). The results of the PXRD analysis indicate that 
the introduction of biomacromolecules (BSA, FBSA, HRP, 
catalase, TR, HGB, AOx, lysozyme, and MB) does not af-
fect the general trend of the product distribution observed 
in the ternary plot (Figure 1b and S1, and S2): i.e. that 
increasing the HmIM/Zn ratio leads to the lower density 
topology sod. However, it is worth noting that the 
amorph-Zn(mIM)2can be transformed to sod-Zn(mIM)2 
by ethanol washing (Figure S10-S13). 
 
Figure 1. (a) Molecular representation of sod-Zn(mIM)2, dia-Zn(mIM)2, and amorph-Zn(mIM)2. (b) and (c) Ternary graphs (by 
volumetric fraction) of 0.33 mg mL-1 aqueous solution of fluorescein-tagged bovine serum albumin (FBSA,), 0.24 M aqueous solu-
tion of Zn(OAc)2·2H2O, and 3.84 M aqueous solution of 2-methylimidazole (HmIM) showing the ZIFs formed at different 
Zn(OAc)2·2H2O concentrations (80 mM, 40 mM, 20 mM, and 10 mM), molar-ratios between HmIM and Zn2+ (HmIM/Zn2+ = 16, 8, 
4, 2, and 1) and mechanical agitation (static (b) and stirred condition (c)). 
An important outcome of this work is that the ternary 
plots provide guidelines for the conditions required to syn-
thesize ZIF biocomposites of predetermined topology. 
High HmIM/Zn ratios and high precursor concentration 
accelerate the ZIF formation and favor the crystallization 
of the kinetic polymorph, sod-Zn(mIM)2. This is consistent 
with reports that ZIF formation is accelerated by the addi-
tion of base to the reaction mixture as it results in a higher 
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concentration of deprotonated HmIM ligands.35 Further-
more, under dilute conditions and/or low HmIM/Zn ratios, 
the reaction kinetics are slower, and the more thermody-
namically stable materials are the predominant products 
(dia-Zn(mIM)2, amorph-Zn(mIM)2, U12, U13, and U14, 
Figure 1b, S1, and S2).12, 25 It is worth noting that the ex-
otic ZIF phase, katsenite (kat), reported by T. Friščić and 
co-authors using a mechanical milling approach,24 and 
seen in another earlier report,36 has been identified in 
the present work as an impurity formed in aqueous con-
ditions. Although the introduction of biomacromolecules 
enhances the ZIF formation kinetics,6 the same ZIF to-
pologies are identified as observed under protein-free 
conditions. This result is strong evidence that the biom-
acromolecules can induce the formation of ZIF structures 
without influencing the final topology. 
 
Figure 2. (a) Schematic diagram demonstrating the synthesis method for FBSA-on-sod-Zn(mIM)2 and the removal of the surface-
adsorbed FBSA on FBSA-on-sod-Zn(mIM)2 by 10% SDS treatment (w/w, in pH 7.5 TBS buffer; SDS = sodium dodecyl sulfate). (b) 
Confocal laser scanning micrographs showing the fluorescence, bright field, and overlay images of FBSA-on-sod-Zn(mIM)2 after 
H2O and EtOH washing and FBSA-on-sod-Zn(mIM)2 after 10% SDS washing. (c) SEM images of the as-synthesized FBSA-on-sod-
Zn(mIM)2 (left) and the sample after 10% SDS washing (right). (d) Experimental PXRD patterns of as-synthesized sod-Zn(mIM)2 
(black), as-synthesized FBSA-on-sod-Zn(mIM)2 (red), and FBSA-on-sod-Zn(mIM)2 after 10% SDS treatment. 
Among the different ZIF polymorphs, sod-Zn(mIM)2 
has been exclusively studied. Presumably this is because 
the open architectures and relatively large pore volumes 
of sod-Zn(mIM)2 have been shown to facilitate selective 
molecular transport from the external environment to the 
encapsulated biomacromolecule.6, 32 This property has al-
lowed biocatalytic reactions to be assessed for sod-
Zn(mIM)2-biocomposites.12 Thus, due to the more densely 
packed, non-porous nature of dia-Zn(mIM)2 U12, and U14 
(Figure S9) we used the sod-Zn(mIM)2-biocomposite for 
further analysis. 
In addition to determining the conditions required to 
synthesize phase pure biocomposites, understanding the 
spatial distribution of the biomacromolecules within the 
sod-Zn(mIM)2 is essential to applications such as bio-
catalysis. Accordingly, BSA was labelled with fluorescein 
isothiocyanate (FITC) to afford fluorophore-tagged protein 
(FBSA), and then confocal laser microscopy (CLSM) was 
employed to ascertain the location of FBSA within the 
sod-Zn(mIM)2-biocomposites. The resulting FBSA-@-




Proteins can be deposited on the outer surface of MOF 
crystals by means of electrostatic interactions, or covalent 
bonding.12 Thus an important first step is the application 
of a washing protocol to remove the surface-adsorbed 
FBSA. This will prevent the observation of fluorecent sig-
nals from non-encapsulated protein. To develop an effec-
tive washing protocol we first synthesized composites 
where FBSA was surface-bound, FBSA-on-sod-
Zn(mIM)2 (Figure 2a). Typically, FBSA-on-sod-Zn(mIM)2 
was synthesized by mixing FBSA with sod-Zn(mIM)2 
crystals in water at room temperature for 1 hour (Figure 
2a). The surface-adsorption of FBSA molecules on sod-
Zn(mIM)2 could be detected by eye as the crystals were 
yellow in appearance. The material was then investigated 
using CLSM and the fluorescent images of the compound 
are shown in Figure 2b. The as-synthesized FBSA-on-
sod-Zn(mIM)2 were subsequently washed twice with wa-
ter and ethanol, followed by 10% surfactant (TritonTM 
X100 (T100) or sodium dodecyl sulfate (SDS), w/w, in 
TBS buffer (pH 7.5)). The CLSM images clearly show that 
water/ethanol and 10% T100 washing are not sufficient to 
remove the surface-adsorbed FBSA on sod-Zn(mIM)2 
(Figure 2b and S15). However, no fluorescence signal 
was observed for FBSA-on-sod-Zn(mIM)2 after 10% SDS 
treatment, indicating complete removal of the adrbed 
FBSA molecules from the surface of sod-Zn(mIM)2 (Fig-
ure 2b). Importantly, PXRD and SEM analysis show that 
the crystallinity and particle morphology of sod-Zn(mIM)2 
are essentially identical subsequent to the washing pro-
cedure (Figure 2c and d). Thus, the following washing pro-
tocol was applied to all samples to ensure the removal of 
surface bound protein: 1) wash twice with H2O and etha-
nol to remove the unreacted precursors; 2) disperse and 
soak crystals in 10% SDS for 30 min at room temperature 
to remove the surface adsorbed biomacromolecules; 3) 
wash twice with TBS buffer and ethanol to remove the re-
sidual SDS. Therefore, the use of this protocol allows for 
selective removal of FBSA from the MOF crystals surface 
without compromising the integrity of the sod-Zn(mIM)2 
particles. 
In a typical experiment for the biomimetically mineral-
ized growth of FBSA/sod-Zn(mIM)2, an aqueous solution 
of 40 mM Zn(OAc)2·2H2O, 640 mM HmIM and 0.33 mg 
mL-1 FBSA was prepared and allowed to stand at room 
temperature for 24 h. We note that static synthetic condi-
tions gave rise to slightly larger crystallites than mechani-
cally stirred reactions (SEM and CLSM images, 1.58 ± 
0.15 versus 1.33 ± 0.14 µm, Figure S16-S21). In addition, 
for a fixed Zn(OAc)2·2H2O concentration, smaller FBSA-
@-sod-Zn(mIM)2 particles can be synthesized by using a 
higher FBSA dosage and/or higher HmIM/Zn ratio in the 
reaction (Figure S16-S21). 
We quantified the FBSA immobilization efficiency by 
dissolving the FBSA-@-sod-Zn(mIM)2 biocomposite in 0.1 
M citric acid-sodium citrate aqueous buffer (pH 5.0) and 
analyzed the FBSA fluorescence signal spectroscopically 
(Table S1). The immobilization efficiency (average of five 
independent analyses) was calculated to be 74-89% be-
fore 10% SDS washing versus 32-45% after 10% SDS 
washing (Table S1). These data confirm that ca. 40% of 
the FBSA is surface bound while ca. 50% is encapsulated 
in the MOF crystal. We acknowledge that the extent of 
encapsulation efficiency is presumably biomacromolecule 
dependent, however, these experiments did address the 
importance of a post-synthetic surfactant washing proce-
dure. Furthermore, CLSM analysis demonstrates that the 
FBSA molecules are predominantly encapsulated in the 
sub-surface region of the sod-Zn(mIM)2 crystallites rather 
than homogeneously distributed throughout the crystal 
(Figure 3).6 These results suggest that under these crys-
tallization conditions, the nucleation of sod-Zn(mIM)2 
does not favor heterogeneous nucleation around FBSA. 
Thus, it is apparent that the encapsulation process is 
mainly based on the adsorption of FBSA on the surfaces 
of the growing ZIF particles. This is analogous to the en-
capsulation mechanism previously reported for nanopar-
ticle/sod-Zn(mIM)2 composites.32 Unfortunately, due to 
the resolution limitation of the CLSM technique, the thick-
ness of the FBSA layer cannot be accurately measured. 
To confirm that the enzymes are not affected by the 
presence of high mIM concentrations and post-synthetic 
washing treatment, we assessed the enzymatic activity of 
HRP, FHRP, and FHRP after controlled release from the 
FHRP-@-sod-Zn(mIM)2 composite as a model study. The 
enzymatic assay showed that the FHRP preserved its en-
zymatic activity after exposure to high concentrations of 
mIM, encapsulation and post-synthetic washing treatment 
(Figure S31 and S32). 
The sub-surface encapsulation of the biomacromole-
cule in sod-Zn(mIM)2 may pose an additional advantage 
with respect to mass-diffusion for catalytic application of 
these materials. On the other hand, the superficial distri-
bution of biomacromolecules in sod-Zn(mIM)2 is likely to 
reduce the protective capacity offered by the ZIF coating. 
We suspected that the fluorophore-functionalization 
would change the surface chemistry of BSA (due to the 
different structures and functionalities of the fluorophores), 
and therefore its affinity towards Zn2+ ions, thus modifying 
the spatial distribution of the biomolecules within sod-
Zn(mIM)2. Besides FITC, rhodamine B isothiocyanate 
(RbITC) is another widely used fluorescent label to modify 
proteins and other biomolecules.37, 38 Compared to fluo-
rescein, rhodamine B contains two tertiary amine groups. 
This chemical difference between will provide a case for 
comparison to understand the effect of surface-function-
alization of biomolecules on biomimetic mineralization 
process. Thus, rhodamine B-tagged BSA (RbBSA) was 
synthesized and used in the biomineralized growth of 
RbBSA/sod-Zn(mIM)2. In contrast to FBSA-@-sod-
Zn(mIM)2, CLSM images indicate that the RbBSA mole-
cules are localized in the center and around the surface 
region of RbBSA/sod-Zn(mIM)2 crystallites. We tested the 
previously developed washing procedure on RbBSA-on-
sod-Zn(mIM)2 crystals to remove the surface-adsorbed 
RbBSA. However, even at elevated temperature (60 °C) 
and prolonged treatment time (24 h), the surface-ad-
sorbed RbBSA could not be removed (Figure S23-S24). 
Thus we could not ascertain whether the fluorescence sig-
nal around the RbBSA-@-sod-Zn(mIM)2 crystallites origi-
nated from surface-adsorbed or superficially localized 
RbBSA. To gain insight into the surface chemistry of the 
fluorophore-tagged BSA, we carried out zeta potential 
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analysis for BSA, FBSA, and RbBSA. The zeta potentials 
of BSA, FBSA, and RbBSA were measured in 640 mM 
HmIM aqueous solution (adjusted to pH 9.5 by 0.1 M HCl) 
to simulate the sod-Zn(mIM)2 biocomposites synthesis 
conditions after mixing of precursors. Interestingly, the 
zeta potential of BSA was minimally affected by the fluo-
rescein-tag (-9.2 ± 1.1 versus -9.4 ± 1.5 mV). However, 
rhodamine B decreased the surface potential of BSA to -
13.5 ± 0.8 mV. These data indicate that RbBSA will have 
a slightly stronger affinity for Zn2+ ions due to more nega-
tive zeta potential, which may explain the centralized lo-
cation of RbBSA observed in RbBSA-@-sod-Zn(mIM)2 as 
this distribution pattern would be induced by heterogene-
ous nucleation process.6, 15 To ascertain the effect of 
chemical functionalization on protein distribution we ex-
amined the CLSM images of biocomposites of fluores-
cein- and rhodamine B-tagged AOx (F-AOx and Rb-AOx), 
HRP (F-HRP and Rb-HRP), HGB (F-HGB and Rb-HGB), 
MB (F-MB and Rb-MB), TR (F-TR and Rb-TR), and ure-
ase (F-urease or Rb-urease) (Figure 3). Similar to BSA, 
CLSM images indicate that the fluorescein-grafted pro-
teins are predominately localized towards the surface of 
the sod-Zn(mIM)2 crystals, while the rhodamine B-grafted 
proteins are centrally localized and surface/sub-surface 
bound (Figure 3). These data clearly show that the spatial 
distribution of biomacromolecules within ZIFs crystallites 
is highly dependent on the surface chemistry of the pro-
tein. 
 
Figure 3. CLSM fluorescence images of sod-Zn(mIM)2 synthesized in the presence of FITC, RbITC, and fluorescein- (or rhodamine 
B-) tagged AOx (F-AOx or Rb-AOx), HRP (F-HRP or Rb-HRP), HGB (F-HGB or Rb-HGB), MB (F-MB or Rb-MB), trypsin (F-TR or 
Rb-TR), and urease (F-urease or Rb-urease). 
To ensure the complete encapsulation of biomacro-
moleules, our results suggest that a secondary ZIF shell 
is necessary. The seed-mediated growth of core-shell 
structured ZIF crystals is well documented in the litera-
ture39 and we explored this strategy to synthesize a multi-
core-shell biomacromolecule-@-sod-Zn(mIM)2 compo-
sites. In addition to offering enhanced protection, this 
strategy also opens up the possibility to precisely con-
trolled the spatial localization of multiple biomacromole-
cules within one sod-Zn(mIM)2 crystal. In a preliminary 
experiment, a sod-Zn(mIM)2 on FBSA-@-sod-Zn(mIM)2 
core-shell structure was synthesized by dispersing 10 mg 
of FBSA-@-sod-Zn(mIM)2 in an aqueous solution of 
HmIM by sonication, followed by the injection of an aque-
ous solution of Zn(OAc)2·2H2O (Figure 4a). The final con-
centrations for HmIM and Zn(OAc)2 in the reaction mixture 
were 640 mM and 40 mM, respectively. The reaction mix-
ture was allowed to stand at room temperature for 24 h. 
PXRD analysis confirmed the phase purity of the sample 
(Figure S27). CLSM and SEM images indicated that the 
synthesis of a core-shell structure was successful (Figure 
4b and Figure S28). Comparison of the particle size dis-
tribution calculated from SEM images of FBSA-@-sod-
Zn(mIM)2 and sod-Zn(mIM)2 on FBSA-@-sod-Zn(mIM)2, 
indicate the sod-Zn(mIM)2 shell was approximately 0.55 
µm (Figure S28). In the present study, up to three layers 
of FBSA-@-sod-Zn(mIM)2 can be grown within one sod-
Zn(mIM)2 crystal (Figure 4c). However, the possibility of 
forming sod-Zn(mIM)2 crystallite with more than tertiary 
growth can reasonably be anticipated. As expected, the 
particle size increase with the introduction of FBSA-@-
sod-Zn(mIM)2 layers (1.58 ± 0.15, 2.20 ± 0.16, and 2.83 
± 0.24 µm for the first, secondary, and tertiary growth 
FBSA-@-sod-Zn(mIM)2, respectively, Figure 4c and 
S30). FBSA loadings were calculated to be similar for the 
first, secondary, and tertiary growth FBSA-@-sod-
Zn(mIM)2 (0.8 ± 0.1 wt%). To assess the permanent po-
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rosity of the core-shell sod-Zn(mIM)2/FBSA biocompo-
sites, 77 K N2 sorption isotherms were measured (Figure 
S29). The BET analysis of the data afforded surface area 
values of 1212.2, 1159.6, and 1072.6 m2 g-1 for the FBSA-
@-sod-Zn(mIM)2 samples after first, secondary, and ter-
tiary growth, showing a decrease of porosity relative to 
pure sod-Zn(mIM)2 (1356.6 m2 g-1). This is consistent with 
the presence of non-porous FBSA in the ZIF crystals; ad-
ditionally this may also be associated with increased de-
fects and the interfaces of the core-shell structures.6 Im-
portantly, the pore size distribution curves calculated from 
77 K N2 adsorption isotherms demonstrated that the pore 
structure of the core-shell material is essentially identical 
to sod-Zn(mIM)2 (Figure S29). The synthesis of biomimet-
ically mineralized core-shell materials offers the potential 
to: 1) incorporate multiple biomacromolecules within a 
single crystal in a spatially controlled manner; 2) to intro-
duce different metal ion and/or imidazole ligand within a 
single biocomposite crystal; 3) control the thickness of 
each layer by modifying the amount of sod-Zn(mIM)2 pre-
cursor in the epitaxial growth reaction. 
 
Figure 4. (a) Schematic diagram demonstrating the synthesis method of the multiple-core-shell FBSA-@-sod-Zn(mIM)2 compo-
site. (b) Confocal laser scanning micrographs showing the fluorescence, bright field, and overlay images of the sod-Zn(mIM)2 on 
FBSA-@-sod-Zn(mIM)2 core-shell structure. The synthesis method for the sod-Zn(mIM)2 shell is analogous to the FBSA-@-sod-
Zn(mIM)2 core, however, without the addition of FBSA. (c) SEM images of the multiple-core-shell FBSA-@-sod-Zn(mIM)2 com-
posites after first (left), secondary (middle), and tertiary (right) growth. Insets of the SEM images show the fluorescence images of 
the corresponding FBSA-@-sod-Zn(mIM)2 composites. Scale bar in the SEM images (blue) and the fluorescence images (red) 
represent 2 µm. (d) Simulated PXRD pattern of the sod-Zn(mIM)2 and the FBSA-@-sod-Zn(mIM)2 samples after epitaxial growth. 
CONCLUSION 
In conclusion, we have established the synthetic con-
ditions required to obtain pure phase biomacromolecule-
@-ZIF composites. Accordingly, this work facilitates the 
design of ZIF-based biocomposites for application to ar-
eas such as bio-catalysis, where control of structure prop-
erties such as pore size is highly desired. Our data shows 
that the concentration of the synthesis precursors play a 
dominant role in the resulting ZIF structure topology, with 
dilute or ligand-deficient ratio yielding less desirable 
dense phases under biomolecule compatible conditions. 
In addition, we have ascertained that the surface chemis-
try of the biomacromolecule appears to influence the spa-
tial location of the protein within the ZIF crystal, thereby 
providing the opportunity to further tune localization and 
properties (i.e. mass transport, improved protection). Re-
liable, enhanced protection and encapsulation was shown 
to be afforded by seed-mediated growth of core-shell 
structured ZIF crystals. This present work has significantly 
advanced the current understanding of the biomimetic 
mineralization process and we envisage that it will provide 
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